These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2100794)

  • 21. Amino acids in liver disease: a cause of hepatic encephalopathy?
    Baker AL
    JAMA; 1979 Jul; 242(4):355-6. PubMed ID: 448942
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapy of hepatic encephalopathy. Changes in the cerebrospinal fluid concentration of catecholamine neurotransmitters, ammonia and amino acids in the course of an infusion treatment with branched-chain amino acids].
    Rössle M; Herz R; Lehmann G; Luft M; Gerok W
    Infusionsther Klin Ernahr; 1982 Oct; 9(5):256-8. PubMed ID: 7141673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Utilization of excess phenylalanine in the diet of rats to obtain an experimental model of phenylketonuria].
    Isacheva NT; Ekimovskiĭ AP
    Vopr Pitan; 1975; (1):40-4. PubMed ID: 1239862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of branched-chain amino acids in liver disease: the evidence for and against.
    Khanna S; Gopalan S
    Curr Opin Clin Nutr Metab Care; 2007 May; 10(3):297-303. PubMed ID: 17414498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe recurrent hepatic encephalopathy that responded to oral branched chain amino acids.
    Chalasani N; Gitlin N
    Am J Gastroenterol; 1996 Jun; 91(6):1266-8. PubMed ID: 8651189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simvastatin for rats with thioacetamide-induced liver failure and encephalopathy.
    Huang HC; Wang SS; Lee FY; Chan CY; Chang FY; Lin HC; Chu CJ; Chen YC; Lee SD
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e236-42. PubMed ID: 17573832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phospholipid and cholesterol alterations accompany structural disarray in myelin membrane of rats with hepatic encephalopathy induced by thioacetamide.
    Swapna I; Kumar KV; Reddy PV; Murthy ChR; Reddanna P; Senthilkumaran B
    Neurochem Int; 2006 Aug; 49(3):238-44. PubMed ID: 16519962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapy of hepatic encephalopathy].
    Egberts EH
    Leber Magen Darm; 1987 Aug; 17(4):244, 247-62, 265-73. PubMed ID: 3312884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Valine and branched-chain amino acids in the treatment of hepatic encephalopathy].
    Grüngreiff K; Kleine FD; Musil HE; Diete U; Franke D; Klauck S; Päge I; Kleine S; Lössner B; Pfeiffer KP
    Z Gastroenterol; 1993 Apr; 31(4):235-41. PubMed ID: 8493803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diet therapy in liver insufficiency].
    Hasik J
    Przegl Epidemiol; 1983; 37(2):255-7. PubMed ID: 6415762
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of a varying body allowance of protein and essential amino acids on the pool of free amino acids in the blood and tissues].
    Mukhamedzhanov EK
    Vopr Pitan; 1988; (2):27-32. PubMed ID: 3388806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diets in Encephalopathy.
    Abdelsayed GG
    Clin Liver Dis; 2015 Aug; 19(3):497-505. PubMed ID: 26195204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapy of hepatic coma].
    Schomerus H
    Z Gastroenterol Verh; 1983 Apr; 18():75-81. PubMed ID: 6192612
    [No Abstract]   [Full Text] [Related]  

  • 34. The effects of maternal protein restriction on the growth of the rat fetus and its amino acid supply.
    Rees WD; Hay SM; Buchan V; Antipatis C; Palmer RM
    Br J Nutr; 1999 Mar; 81(3):243-50. PubMed ID: 10434851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of branched-chain amino acid infusion on protein metabolism in rats with acute hepatic failure.
    Miwa Y; Kato M; Moriwaki H; Okuno M; Sugihara J; Ohnishi H; Yoshida T; Muto Y; Nakayama M; Morioka Y
    Hepatology; 1995 Jul; 22(1):291-6. PubMed ID: 7601423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic hepatic encephalopathy. Long-term therapy with a branched-chain amino-acid-enriched elemental diet.
    Freund H; Yoshimura N; Fischer JE
    JAMA; 1979 Jul; 242(4):347-9. PubMed ID: 36486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement in the nutritional status and clinical conditions of patients with liver failure using a liver diet combined with a branched chain amino acids-enriched elemental diet.
    Matsuoka S; Tamura A; Nakagawara H; Moriyama M
    Hepatogastroenterology; 2014; 61(133):1308-12. PubMed ID: 25436302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nutritional management of hepatic encephalopathy.
    Bower RH; Fischer JE
    Adv Nutr Res; 1983; 5():1-11. PubMed ID: 6133418
    [No Abstract]   [Full Text] [Related]  

  • 39. Direct Comparison of the Thioacetamide and Azoxymethane Models of Type A Hepatic Encephalopathy in Mice.
    Grant S; McMillin M; Frampton G; Petrescu AD; Williams E; Jaeger V; Kain J; DeMorrow S
    Gene Expr; 2018 Aug; 18(3):171-185. PubMed ID: 29895352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amino acid disturbances in experimental hepatic coma rats.
    Shi ZQ; Chang TM
    Int J Artif Organs; 1984 Jul; 7(4):197-202. PubMed ID: 6490191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.